JP2023543801A5 - - Google Patents
Info
- Publication number
- JP2023543801A5 JP2023543801A5 JP2023519066A JP2023519066A JP2023543801A5 JP 2023543801 A5 JP2023543801 A5 JP 2023543801A5 JP 2023519066 A JP2023519066 A JP 2023519066A JP 2023519066 A JP2023519066 A JP 2023519066A JP 2023543801 A5 JP2023543801 A5 JP 2023543801A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- composition according
- cells
- cell
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083392P | 2020-09-25 | 2020-09-25 | |
| US63/083,392 | 2020-09-25 | ||
| PCT/US2021/052017 WO2022067076A1 (en) | 2020-09-25 | 2021-09-24 | Retro-inverso regulatory t cell epitopes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543801A JP2023543801A (ja) | 2023-10-18 |
| JP2023543801A5 true JP2023543801A5 (https=) | 2024-10-02 |
Family
ID=80845816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519066A Pending JP2023543801A (ja) | 2020-09-25 | 2021-09-24 | レトロインベルソ制御性ｔ細胞エピトープ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240173377A1 (https=) |
| EP (1) | EP4216984A4 (https=) |
| JP (1) | JP2023543801A (https=) |
| KR (1) | KR20230074517A (https=) |
| AU (1) | AU2021350011A1 (https=) |
| CA (1) | CA3193819A1 (https=) |
| MX (1) | MX2023003426A (https=) |
| WO (1) | WO2022067076A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM411994A0 (en) * | 1994-02-25 | 1994-03-24 | Deakin Research Limited | Epitopes |
| EP2450368A1 (en) * | 2007-01-30 | 2012-05-09 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| WO2012142022A1 (en) * | 2011-04-11 | 2012-10-18 | The General Hospital Corporation | Assays, compositions, systems, kits, and devices for diagnosing typhoid fever |
| MY202858A (en) * | 2016-06-10 | 2024-05-25 | Eisai R&D Man Co Ltd | Lysine conjugated immunoglobulins |
| WO2019071116A1 (en) * | 2017-10-05 | 2019-04-11 | Epivax, Inc. | T REGULATORY LYMPHOCYTE EPITOPES |
-
2021
- 2021-09-24 AU AU2021350011A patent/AU2021350011A1/en not_active Abandoned
- 2021-09-24 WO PCT/US2021/052017 patent/WO2022067076A1/en not_active Ceased
- 2021-09-24 EP EP21873543.9A patent/EP4216984A4/en active Pending
- 2021-09-24 JP JP2023519066A patent/JP2023543801A/ja active Pending
- 2021-09-24 KR KR1020237013399A patent/KR20230074517A/ko not_active Withdrawn
- 2021-09-24 US US18/044,876 patent/US20240173377A1/en active Pending
- 2021-09-24 CA CA3193819A patent/CA3193819A1/en active Pending
- 2021-09-24 MX MX2023003426A patent/MX2023003426A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103415620B (zh) | 诱导针对EGFRvIII的免疫应答的方法和组合物 | |
| CN109535228B (zh) | 用作诱发抗原特异性t细胞反应的免疫原性增强剂的融合蛋白 | |
| JP6041851B2 (ja) | フラジェリンに基づく新規の免疫アジュバント化合物及びその使用 | |
| JP4713809B2 (ja) | Ｂ型肝炎コア抗原融合タンパク質 | |
| CN102119033B (zh) | 用于增强促生长素抑制素免疫原性的组合物和方法 | |
| JP6530742B2 (ja) | 腸内病原体の免疫応答を強化する組成物及び方法 | |
| EP3964532A1 (en) | Fusion protein capable of self-assembling into protein nanoparticles and application thereof | |
| JP2004527213A5 (https=) | ||
| CN112062862A (zh) | 疫苗通用载体及其制备方法和应用 | |
| CN102149406A (zh) | 用于治疗丙型肝炎的组合物和方法 | |
| CN102037135A (zh) | 增强对有鞭毛的细菌的免疫反应的组合物和方法 | |
| EA016818B1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| CN107847575A (zh) | 用于猪生殖与呼吸综合症及猪圆环病毒相关疾病的疫苗组合物 | |
| KR20230084478A (ko) | 면역원성 코로나 바이러스 융합 단백질 및 관련 방법 | |
| WO2024067888A1 (zh) | 一种预防或治疗水痘-带状疱疹病毒相关疾病的免疫组合物产品及其制备方法 | |
| CN100467063C (zh) | 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用 | |
| WO2024222926A1 (zh) | 可自组装为纳米颗粒的融合蛋白及其在免疫中的应用 | |
| JP2010535504A5 (https=) | ||
| JP2005518194A (ja) | 乱交雑ｔ細胞エピトープ挿入物を有するマルチマータンパク質の免疫原性擬態物 | |
| JP4299777B2 (ja) | 免疫応答を誘導するための方法および組成物 | |
| JP7585480B2 (ja) | Ｐｄ－ｌ１の細胞外ドメインを含むキメラ抗原 | |
| JP2023543801A5 (https=) | ||
| EP0427768A1 (en) | Polypeptide pertussis toxin vaccine | |
| EP3517542B1 (en) | Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide | |
| CN113476600B (zh) | Avc-29作为疫苗佐剂的用途以及含有该佐剂的疫苗组合物 |